Juan Antonio Valera Calero, PhD

CONTACT

Lead Sponsor

Universidad Complutense de Madrid

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Adults
•Presence of shoulder pain for at least 3 months.
•Shoulder pain intensity greater than 3 points on the visual analogue scale (VAS).
•Shoulder-related disability greater than 20 points on the DASH questionnaire.
•Presence of at least one active myofascial trigger point in the infraspinatus muscle.
•Reproduction of the patient's familiar shoulder pain during palpation of the infraspinatus trigger point.
•Ability to understand the study procedures and provide written informed consent.

•Previous shoulder surgery or traumatic shoulder injury in the affected region.
•Presence of severe structural or systemic pathology affecting the shoulder region, such as fracture, tumour, infection, inflammatory disease, or neurological disorder.
•Clinical signs suggestive of cervical radiculopathy or other neurological conditions that could explain the shoulder symptoms.
•Use of physiotherapy treatment, invasive therapy, or analgesic/anti-inflammatory medication during the week before participation.
•Contraindications to dry needling or percutaneous electrolysis, including needle phobia, anticoagulant therapy, bleeding disorders, pregnancy, pacemaker or implanted electrical devices, local skin infection, or altered skin sensitivity in the treatment area.

Related studies

NCT07624136 · Subacromial Impingement Syndrome, Shoulder Pain

NCT07203222 · Hemiplegic Shoulder Pain

NCT07360847 · Rotator Cuff Related Shoulder Pain, RCRSP

NCT07493226 · Frozen Shoulder, Adhesive Capsulitis, and more

NCT05328401 · Post Stroke Shoulder Pain

Dry Needling or Percutaneous Electrolysis for Managing Myofascial Trigger Points?